HRP20030433B1 - Dermatological formulations containing clindamycin and a zinc-salt - Google Patents

Dermatological formulations containing clindamycin and a zinc-salt

Info

Publication number
HRP20030433B1
HRP20030433B1 HR20030433A HRP20030433A HRP20030433B1 HR P20030433 B1 HRP20030433 B1 HR P20030433B1 HR 20030433 A HR20030433 A HR 20030433A HR P20030433 A HRP20030433 A HR P20030433A HR P20030433 B1 HRP20030433 B1 HR P20030433B1
Authority
HR
Croatia
Prior art keywords
zinc
salt
formulations containing
dermatological formulations
containing clindamycin
Prior art date
Application number
HR20030433A
Other languages
English (en)
Croatian (hr)
Inventor
Louise Kanis Rebecca
Louise Mcdonagh Emma
Original Assignee
Kanford B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanford B.V. filed Critical Kanford B.V.
Publication of HRP20030433A2 publication Critical patent/HRP20030433A2/hr
Publication of HRP20030433B1 publication Critical patent/HRP20030433B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HR20030433A 2000-11-28 2003-05-28 Dermatological formulations containing clindamycin and a zinc-salt HRP20030433B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations
PCT/GB2001/005257 WO2002043739A2 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Publications (2)

Publication Number Publication Date
HRP20030433A2 HRP20030433A2 (en) 2004-08-31
HRP20030433B1 true HRP20030433B1 (en) 2007-10-31

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030433A HRP20030433B1 (en) 2000-11-28 2003-05-28 Dermatological formulations containing clindamycin and a zinc-salt

Country Status (25)

Country Link
US (2) US20040109902A1 (xx)
EP (1) EP1347765B1 (xx)
JP (1) JP4272425B2 (xx)
KR (1) KR100629326B1 (xx)
AT (1) ATE321560T1 (xx)
AU (2) AU2309102A (xx)
BR (1) BR0115727A (xx)
CA (1) CA2429205C (xx)
CZ (1) CZ305272B6 (xx)
DE (1) DE60118441T2 (xx)
DK (1) DK1347765T3 (xx)
ES (1) ES2263689T3 (xx)
GB (1) GB0029018D0 (xx)
HK (1) HK1059218A1 (xx)
HR (1) HRP20030433B1 (xx)
HU (1) HUP0400520A3 (xx)
IL (1) IL152720A0 (xx)
MX (1) MXPA03004733A (xx)
NZ (1) NZ526170A (xx)
PL (1) PL207221B1 (xx)
PT (1) PT1347765E (xx)
RU (1) RU2277419C2 (xx)
SK (1) SK288111B6 (xx)
WO (1) WO2002043739A2 (xx)
ZA (1) ZA200305012B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
MX2010005786A (es) * 2007-11-30 2010-06-09 Novartis Ag Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol.
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
AU703926B2 (en) * 1994-03-28 1999-04-01 Trustees Of Columbia University In The City Of New York, The Composition for inactivating irritants in fluids
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
AU2002223091B2 (en) 2006-08-31
AU2309102A (en) 2002-06-11
HUP0400520A3 (en) 2012-08-28
CA2429205A1 (en) 2002-06-06
JP2004517829A (ja) 2004-06-17
ZA200305012B (en) 2005-04-26
ATE321560T1 (de) 2006-04-15
HUP0400520A2 (hu) 2004-07-28
US20100173855A1 (en) 2010-07-08
DK1347765T3 (da) 2006-08-07
US20040109902A1 (en) 2004-06-10
RU2277419C2 (ru) 2006-06-10
PL207221B1 (pl) 2010-11-30
PL362279A1 (en) 2004-10-18
DE60118441D1 (de) 2006-05-18
EP1347765A2 (en) 2003-10-01
SK6322003A3 (en) 2003-12-02
MXPA03004733A (es) 2005-02-14
SK288111B6 (sk) 2013-08-02
CZ20031491A3 (cs) 2004-01-14
GB0029018D0 (en) 2001-01-10
EP1347765B1 (en) 2006-03-29
ES2263689T3 (es) 2006-12-16
JP4272425B2 (ja) 2009-06-03
CZ305272B6 (cs) 2015-07-15
HRP20030433A2 (en) 2004-08-31
IL152720A0 (en) 2003-06-24
CA2429205C (en) 2010-11-16
KR100629326B1 (ko) 2006-09-29
PT1347765E (pt) 2006-08-31
NZ526170A (en) 2006-01-27
HK1059218A1 (en) 2004-06-25
US8268790B2 (en) 2012-09-18
KR20030069793A (ko) 2003-08-27
WO2002043739A2 (en) 2002-06-06
DE60118441T2 (de) 2006-11-16
BR0115727A (pt) 2003-10-14
WO2002043739A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HRP20030433B1 (en) Dermatological formulations containing clindamycin and a zinc-salt
BR0107649B1 (pt) Composição herbicida compreendendo ácido 4-amino-3,6-dicloropiridina-2-carboxílico ou um derivado do mesmo e método para controlar vegetação indesejável.
DE69834339D1 (de) Verwendung einer zusammensetzung die einen chelatbildner und eine antimikrobielle verbindung enthaltet zur behandlung von biofilmen
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
MX2007006861A (es) Composiciones que tienen alta eficacia antiviral y antibacterial.
EP1311269A4 (en) PROCESS FOR USE OF DIKETOPIPERAZINES AND COMPOSITIONS THEREOF CONTAINING THEM
BR9806118A (pt) Processos para tratamento de pigmentação de pele
HK1093678A1 (en) Cosmetic composition containing nicotinamide and self tanning agent for use as self tanning composition
HK1053603A1 (en) Medicament based on gestagens for dermal application comprising ascorbic acid and/or salts thereof
EP1145719A3 (en) Use a ferrous salt for inhibiting oxidative degradation of pharmaceutical formulations
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
BG108009A (en) Complex of modafinil and cyclodextrin
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
NO982775L (no) Sammensetning inneholdende et soppmiddel og en svovelforbindelse
ATE261440T1 (de) Pyridinsulfonylharnstoffderivate mit herbizider wirkung
ATE316782T1 (de) Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
TR200401573T4 (tr) Stabilize edilmiş granülosit koloni uyarıcı faktör
WO2001062208A3 (de) Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
AU5050601A (en) Phosphine compounds and their use as tanning agents, corrosion inhibitors and biocides
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
WO2002038110A3 (fr) Utilisation de carbohydrate pour ameliorer la fonction barriere de la peau
WO2002056680A3 (en) Fungicidal and bactericidal compositions for plants containing phosphonate and phosphate salts, metal chelates, and derivatives thereof
DK1046337T3 (da) Vamdbaserede præparater med fungicid virkning

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: KANFORD B.V., NL

Owner name: STRAKAN INTERNATIONAL LIMITED, BM

PPPP Transfer of rights

Owner name: STRAKAN INTERNATIONAL LIMITED, GB

ODRP Renewal fee for the maintenance of a patent

Payment date: 20111126

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20121129